Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
Healthcare
$27.69 +1.77%
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
52W Low $24.15High $32.23
Volume 0.40M
Average 0.51M
AVLN Common Stock Issued
Cash raised by issuing new shares.
No reported Common Stock Issued figures are available to summarize.
Common Stock Issued history
Currency unavailable · from the cash flow
No Common Stock Issued data reported for this period type.
Common Stock Issued vs competitors
How AVLN compares with its peers on the latest reported figures
AVLN Competitors
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 455.08M SEK | -48.4% | +31.5% | 34217.5% |
| LTM Jun 2026 | $127.11M USD | -90.0% | +48.6% | 11.2% | |
| LTM Mar 2026 | $23.34M USD | +1915.5% | — | 19.9% | |
| LTM Mar 2026 | $2.26M USD | +161.5% | -55.5% | 0.6% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | +56.5% | +31.5% | 15.6% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Currency unavailable
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.